Moffitt at SITC

We are excited to participate in the Society for Immunotherapy of Cancer Annual Meeting from November 1-5.

Moffitt Cancer Center's research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. As pioneers of immunotherapy as a groundbreaking cancer treatment, we are excited to participate in the Society for Immunotherapy of Cancer Annual Meeting from November 1-5. The studies our scientists present explore many advances in areas like radiomics, checkpoint inhibitors and TIL therapy covering many cancer types. Be sure to visit our Booth #428 to meet members of the team and learn more about the impact Moffitt is making in cancer research, outcomes and advancements.

To learn more about Moffitt’s research and breakthroughs, follow Moffitt on LinkedIn and Twitter (@MoffittNews) or subscribe to one of our newsletters.

2023 Featured Articles

New Approach Using mRNA Generates Cellular Immunotherapy Within the Body
In vivo CAR macrophage therapy can be used to treat solid tumors

Immunotherapy Clinical Trial Tackles Barriers to Treating Uveal Melanoma Liver Metastasis
Therapy uses a pressure enabled delivery system to deliver immunotherapy to the tumor

Moffitt Study Aims to Improve Personalized Cancer Vaccines
Selection of neoantigen target critical to therapy’s success

Press Contact

Kim Polacek

Kim Polacek, APR, CPRC

Senior PR Account Coordinator

813-456-3342

2023 Videos

Moffitt Resources

Office of Innovation

The Office of Innovation and Industry Alliances is charged with advancing Moffitt discoveries by forging alliances with industry, licensing technologies, and supporting startups to bring cutting edge

Research Careers

Our researchers drive cutting-edge discoveries that are rapidly translated into improved diagnostic, preventive and therapeutic advances.

Diversity and Inclusion

Maintaining a diverse faculty and trainee group encourages the exchange of ideas and differing points of view.

Clinical Trials

Physicians and researchers work close together to provide innovative treatment options for patients. Moffitt participates in over 350 clinical trials. Find a trial that is right for you.

Cell Therapies

The overall goal of the Cell Therapies Core (CTC) is to provide service to members to facilitate translation of promising therapies for patients with cancer.

Physician Relations

Please feel free to contact the physician liaison team for support or to schedule an office visit.

Medical staff with a patient getting an IV

Nationally Ranked. Florida's Best.

With survival rates up to four times the national averages, Moffitt can be your best chance for beating cancer. Our multispecialty medical professionals are dedicated to the treatment and research of cancer.

Choose Moffitt First